Celldex drug barzolvolimab has mid-stage results in a chronic inflammatory skin disease that top those of an approved Genentech drug and two experimental Novartis therapies. The biotech is preparing to advance its drug to Phase 3 testing in 2024.
The Institute of Medicine's "The Future of Nursing: Leading Change, Advancing Health" is a logical read and echos what nurse practitioners (NPs), patients and some other professions have been saying for years: let NPs do the work they are educated and trained to do without arbitrary and archaic state and/or federal barriers, according to A Nurse Practitioner's View blog.
This eBook, in collaboration with Care Logistics, details how hospitals and health systems can facilitate more effective decision-making by operationalizing elevated awareness.